$Esperion Therapeutics (ESPR.US)$ Some great info on Esperio...
$Esperion Therapeutics(ESPR.US$ Some great info on Esperion, its FDA approved drugs Nexletol which is Bempedoic Acid and Nexlizet drug (Bempedoic Acid and Ezetimibe) showing why Esperion will be a blockbuster.
Bempedoic acid for statin intolerant patients? This #2023 trial is the first positive outcomes trial for this lipid lowering drug — and THE FIRST to SHOW non-statin benefit in primary prevention. CLEAR Outcomes Trial, NEJM 2023
Bempedoic acid for statin intolerant patients? This #2023 trial is the first positive outcomes trial for this lipid lowering drug — and THE FIRST to SHOW non-statin benefit in primary prevention. CLEAR Outcomes Trial, NEJM 2023
https://twitter.com/CardiacTrials/status/1725956351107690676
Also check out Brinks2009 on Twitter video, his friend borrowed his Porsche GT3RS and talks about Nexlizet
https://twitter.com/Brinkswealth10/status/1726291148879315317
Esperion stock is very undervalued in my opinion, I expect a favorabe ruling before the end of this year for the $300 million owed to ESPR from it's partner Daiichi Sankyo Europe DSE. Stock should jump to $4 on the ruling this year. The next big upside will come on Label change
https://twitter.com/Brinkswealth10/status/1725199120309293245
Doctor Peter Attia, a famous Doctor is now using Nexlizet. https://podclips.com/c/to-keep-apob-40-mgdl-peter-takes-repatha-pcsk9-inhibitor-nexlizet-bempedoic-acid-ezetimibe
This stock will get more upside than $AMC Entertainment(AMC.US$ and $GameStop(GME.US$ and $NVIDIA(NVDA.US$ AND $Tesla(TSLA.US$ $Apple(AAPL.US$ next year ESPR will get to 250k prescriptions and be up 10 times it's current price. The stock will get to $30 to $40 when it gets to 1 million scripts in 2025. Do you research on this company. If you are in $Ginkgo Bioworks(DNA.US$ $SoundHound AI(SOUN.US$ $BigBear.ai Holdings(BBAI.US$ $Nikola(NKLA.US$ Consider picking up some ESPR. It will reward you.
Also check out Brinks2009 on Twitter video, his friend borrowed his Porsche GT3RS and talks about Nexlizet
https://twitter.com/Brinkswealth10/status/1726291148879315317
Esperion stock is very undervalued in my opinion, I expect a favorabe ruling before the end of this year for the $300 million owed to ESPR from it's partner Daiichi Sankyo Europe DSE. Stock should jump to $4 on the ruling this year. The next big upside will come on Label change
https://twitter.com/Brinkswealth10/status/1725199120309293245
Doctor Peter Attia, a famous Doctor is now using Nexlizet. https://podclips.com/c/to-keep-apob-40-mgdl-peter-takes-repatha-pcsk9-inhibitor-nexlizet-bempedoic-acid-ezetimibe
This stock will get more upside than $AMC Entertainment(AMC.US$ and $GameStop(GME.US$ and $NVIDIA(NVDA.US$ AND $Tesla(TSLA.US$ $Apple(AAPL.US$ next year ESPR will get to 250k prescriptions and be up 10 times it's current price. The stock will get to $30 to $40 when it gets to 1 million scripts in 2025. Do you research on this company. If you are in $Ginkgo Bioworks(DNA.US$ $SoundHound AI(SOUN.US$ $BigBear.ai Holdings(BBAI.US$ $Nikola(NKLA.US$ Consider picking up some ESPR. It will reward you.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
youreatowel : Tesla to the moooooon